In Vitro Low-Level Resistance to Azoles in Candida albicans Is Associated with Changes in Membrane Lipid Fluidity and Asymmetry
Open Access
- 1 April 2002
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 46 (4) , 1046-1052
- https://doi.org/10.1128/aac.46.4.1046-1052.2002
Abstract
The present study tracks the development of low-level azole resistance in in vitro fluconazole-adapted strains of Candida albicans , which were obtained by serially passaging a fluconazole-susceptible dose-dependent strain, YO1-16 (fluconazole MIC, 16 μg ml −1 ) in increasing concentrations of fluconazole, resulting in strains YO1-32 (fluconazole MIC, 32 μg ml −1 ) and YO1-64 (MIC, 64 μg ml −1 ). We show that acquired resistance to fluconazole in this series of isolates is not a random process but is a gradually evolved complex phenomenon that involves multiple changes, which included the overexpression of ABC transporter genes, e.g., CDR1 and CDR2 , and the azole target enzyme, ERG11 . The sequential rise in fluconazole MICs in these isolates was also accompanied by cross-resistance to other azoles and terbinafine. Interestingly, fluorescent polarization measurements performed by using the fluorescent probe 1,6-diphenyl-1,3,5-hexatriene revealed that there was a gradual increase in membrane fluidity of adapted strains. The increase in fluidity was reflected by observed change in membrane order, which was considerably decreased (decrease in fluorescence polarization values, P value) in the adapted strain ( P value of 0.1 in YO1-64, compared to 0.19 in the YO1-16 strain). The phospholipid composition of the adapted strain was not significantly altered; however, ergosterol content was reduced in YO1-64 from that in the YO1-16 strain. The asymmetrical distribution of phosphatidylethanolamine (PE) between two monolayers of plasma membrane was also changed, with PE becoming more exposed to the outer monolayer in the YO1-64 strain. The results of the present study suggest for the first time that changes in the status of membrane lipid phase and asymmetry could contribute to azole resistance in C. albicans .Keywords
This publication has 35 references indexed in Scilit:
- In Vitro Resistance of Staphylococcus aureus to Thrombin-Induced Platelet Microbicidal Protein Is Associated with Alterations in Cytoplasmic Membrane FluidityInfection and Immunity, 2000
- Rhodamine 6G efflux for the detection of CDR1-overexpressing azole-resistant Candidaalbicans strainsJournal of Antimicrobial Chemotherapy, 1999
- The yeast multidrug resistance pump, Pdr5p, confers reduced drug resistance in erg mutants of Saccharomyces cerevisiaeMicrobiology, 1999
- Membrane fluidity affects functions of Cdr1p, a multidrug ABC transporter ofCandida albicansFEMS Microbiology Letters, 1999
- Expression ofCDR1, a multidrug resistance gene ofCandida albicans: transcriptional activation by heat shock, drugs and human steroid hormonesFEMS Microbiology Letters, 1998
- Development of Interpretive Breakpoints for Antifungal Susceptibility Testing: Conceptual Framework and Analysis of In Vitro-In Vivo Correlation Data for Fluconazole, Itraconazole, and Candida InfectionsClinical Infectious Diseases, 1997
- Functional study of multidrug resistance with fluorescent dyes. Limits of the assay for low levels of resistance and application in clinical samplesCancer Letters, 1996
- Stress signaling in yeastBioEssays, 1995
- Emerging role of lipids of Candida albicans, a pathogenic dimorphic yeastBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1992
- The Lipid Composition of Azole-sensitive and Azole-resistant Strains of Candida albicansMicrobiology, 1986